| Prev Close: | 34.95 |
|---|---|
| Open: | 35.06 |
| Bid: | 21.77 x 500 |
| Ask: | N/A |
| 1y Target Est: | 39.65 |
| Beta: | 1.32 |
| Next Earnings Date: | 29-Jul-13 |
| Day's Range: | 34.68 - 35.36 |
|---|---|
| 52wk Range: | 21.33 - 40.87 |
| Volume: | 291,793 |
| Avg Vol (3m): | 444,588 |
| Market Cap: | 1.39B |
| P/E (ttm): | 9.59 |
| EPS (ttm): | 3.63 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- 5 Stocks Poised for Breakoutsat TheStreet(Fri, Jun 7)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a VotEDGAR Online(Tue, Jun 4)
- 2 Buys, 1 Sell In This Year's Biotech Surgeat Seeking Alpha(Thu, May 30)
- New Memoir by Singer/Songwriter Kristie Salerno Kent Follows Her Journey as a Multiple Sclerosis Patient AdvocateBusiness Wire(Wed, May 29)
- Acorda to Present New Research on AMPYRA® at Fifth Cooperative Meeting of CMSC and ACTRIMSBusiness Wire(Tue, May 28)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, May 28)
- Alkermes Earnings Beat Estimates, But Outlook Unclearat Investor's Business Daily(Thu, May 23)
- Alkermes posts 4Q profit as royalty payments riseAP(Thu, May 23)
- Alkermes Earnings Seen Rising, But Sales Uncertainat Investor's Business Daily(Wed, May 22)
- Additional Patent for Acorda's AmpyraZacks(Wed, May 22)
- CORRECTING and REPLACING Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple SclerosisBusiness Wire(Tue, May 21)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, May 21)
- 4 Healthcare Stock Stories Prescribed For Investorsat Wall St. Cheat Sheet(Mon, May 20)
- Acorda Therapeutics Announces Issuance of Additional U.S. Patent for AMPYRA® Covering a Range of Dosage StrengthsBusiness Wire(Mon, May 20)
- ACORDA THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Mon, May 20)
Press Releases
- New Memoir by Singer/Songwriter Kristie Salerno Kent Follows Her Journey as a Multiple Sclerosis Patient AdvocateBusiness Wire(Wed, May 29)
- Acorda to Present New Research on AMPYRA® at Fifth Cooperative Meeting of CMSC and ACTRIMSBusiness Wire(Tue, May 28)
- CORRECTING and REPLACING Acorda Therapeutics Announces Publication of New Data on Impact of Mobility Impairment Due to Multiple SclerosisBusiness Wire(Tue, May 21)
Reports
- ACOR: Due Diligence Review: Forensic Earnings and ValuationNew Constructs, LLC(Jun 19)
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(Jun 19)
- Trading Report for (ACOR). A detailed report, including free correlated market...Stock Traders Daily(Jun 19)